Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.29
(-3.33%)
AUD 0.29
(-3.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 4.36 Million AUD | 41.5% |
| 2022 | 3.08 Million AUD | 88.41% |
| 2021 | 1.63 Million AUD | 45.97% |
| 2020 | 1.12 Million AUD | 65.05% |
| 2019 | 679.62 Thousand AUD | -47.26% |
| 2018 | 1.28 Million AUD | 825.03% |
| 2017 | 139.29 Thousand AUD | -21.31% |
| 2016 | 177.02 Thousand AUD | 55.48% |
| 2015 | 113.85 Thousand AUD | 17.2% |
| 2014 | 97.14 Thousand AUD | 25001.29% |
| 2013 | 387.00 AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 2.38 Million AUD | 0.0% |
| 2024 Q4 | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | 4.36 Million AUD | 0.0% |
| 2023 FY | 4.36 Million AUD | 41.5% |
| 2022 Q4 | 3.08 Million AUD | 0.0% |
| 2022 FY | 3.08 Million AUD | 88.41% |
| 2022 Q2 | - AUD | 0.0% |
| 2021 Q2 | 640.04 Thousand AUD | 0.0% |
| 2021 FY | 1.63 Million AUD | 45.97% |
| 2021 Q4 | 997.33 Thousand AUD | 0.0% |
| 2020 FY | 1.12 Million AUD | 65.05% |
| 2020 Q4 | 50 Thousand AUD | 0.0% |
| 2020 Q2 | 1.07 Million AUD | 0.0% |
| 2019 FY | 679.62 Thousand AUD | -47.26% |
| 2019 Q2 | 679.62 Thousand AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q2 | 426.92 Thousand AUD | 0.0% |
| 2018 FY | 1.28 Million AUD | 825.03% |
| 2018 Q4 | 861.59 Thousand AUD | 0.0% |
| 2017 Q4 | 139.29 Thousand AUD | 0.0% |
| 2017 FY | 139.29 Thousand AUD | -21.31% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | 177.02 Thousand AUD | 55.48% |
| 2016 Q4 | 39.96 Thousand AUD | 0.0% |
| 2016 Q2 | 137.05 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 FY | 113.85 Thousand AUD | 17.2% |
| 2015 Q2 | 21.00 AUD | 0.0% |
| 2015 Q4 | 113.83 Thousand AUD | 0.0% |
| 2014 FY | 97.14 Thousand AUD | 25001.29% |
| 2013 FY | 387.00 AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | 100.0% |
| Acrux Limited | 5.09 Million AUD | 100.0% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 100.0% |
| BTC Health Limited | 16.36 Thousand AUD | 100.0% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 100.0% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.0% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 100.0% |
| Biome Australia Limited | 13 Million AUD | 100.0% |
| Hexima Limited | - AUD | NaN% |
| Immutep Limited | 3.5 Million AUD | 100.0% |
| Memphasys Limited | 60 Thousand AUD | 100.0% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 100.0% |
| Noxopharm Limited | 2.4 Million AUD | 100.0% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 100.0% |
| Race Oncology Limited | 4 Million AUD | 100.0% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 100.0% |
| Starpharma Holdings Limited | 8.28 Million AUD | 100.0% |
| Tissue Repair Ltd | 152.24 Thousand AUD | 100.0% |
| Biotron Limited | - AUD | NaN% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 100.0% |
| CSL Limited | 22.41 Billion AUD | 100.0% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 100.0% |
| Anatara Lifesciences Ltd | - AUD | NaN% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | 100.0% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | 100.0% |
| Patrys Limited | 1.39 Million AUD | 100.0% |
| Orthocell Limited | 5.31 Million AUD | 100.0% |
| Imugene Limited | - AUD | NaN% |
| PYC Therapeutics Limited | 22.05 Million AUD | 100.0% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 100.0% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 100.0% |
| Arovella Therapeutics Limited | 17 Thousand AUD | 100.0% |
| Nanollose Limited | 12.5 Thousand AUD | 100.0% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 100.0% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | NaN% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 100.0% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 100.0% |
| Nyrada Inc. | - AUD | NaN% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 100.0% |
| Dimerix Limited | 583.47 Thousand AUD | 100.0% |
| PharmAust Limited | - AUD | NaN% |
| AnteoTech Limited | 460.39 Thousand AUD | 100.0% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 100.0% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 100.0% |
| Actinogen Medical Limited | 9.93 Million AUD | 100.0% |
| Immuron Limited | 4.9 Million AUD | 100.0% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 100.0% |